Growing adoption of first-line preventive therapies to accelerate revenues in the global postmenopausal osteoporosis drugs market by 2020
This market research study presents a detailed segmentation of the global postmenopausal osteoporosis drugs market by therapeutic class (antiresorptive medications and anabolic medications), by line of therapy (first line of therapy and second line of therapy), and by geography (the Americas, APAC, and EMEA). Leading vendors in this market are Eli Lilly, Amgen, Merck,…